Literature DB >> 12885919

Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses.

David H O'Connor1, Bianca R Mothe, Jason T Weinfurter, Sarah Fuenger, William M Rehrauer, Peicheng Jing, Richard R Rudersdorf, Max E Liebl, Kendall Krebs, Joshua Vasquez, Elizabeth Dodds, John Loffredo, Sarah Martin, Adrian B McDermott, Todd M Allen, Chenxi Wang, G G Doxiadis, David C Montefiori, Austin Hughes, Dennis R Burton, David B Allison, Steven M Wolinsky, Ronald Bontrop, Louis J Picker, David I Watkins.   

Abstract

Certain major histocompatibility complex class I (MHC-I) alleles are associated with delayed disease progression in individuals infected with human immunodeficiency virus (HIV) and in macaques infected with simian immunodeficiency virus (SIV). However, little is known about the influence of these MHC alleles on acute-phase cellular immune responses. Here we follow 51 animals infected with SIV(mac)239 and demonstrate a dramatic association between Mamu-A*01 and -B*17 expression and slowed disease progression. We show that the dominant acute-phase cytotoxic T lymphocyte (CTL) responses in animals expressing these alleles are largely directed against two epitopes restricted by Mamu-A*01 and one epitope restricted by Mamu-B*17. One Mamu-A*01-restricted response (Tat(28-35)SL8) and the Mamu-B*17-restricted response (Nef(165-173)IW9) typically select for viral escape variants in early SIV(mac)239 infection. Interestingly, animals expressing Mamu-A*1 and -B*17 have less variation in the Tat(28-35)SL8 epitope during chronic infection than animals that express only Mamu-A*01. Our results show that MHC-I alleles that are associated with slow progression to AIDS bind epitopes recognized by dominant CTL responses during acute infection and underscore the importance of understanding CTL responses during primary HIV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885919      PMCID: PMC167227          DOI: 10.1128/jvi.77.16.9029-9040.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Differences between T cell epitopes recognized after immunization and after infection.

Authors:  Thorsten U Vogel; Helen Horton; Deborah H Fuller; Donald K Carter; Kathy Vielhuber; David H O'Connor; Tim Shipley; Jim Fuller; Gerd Sutter; Volker Erfle; Nancy Wilson; Louis J Picker; David I Watkins
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

2.  Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?

Authors:  Thorsten U Vogel; Thomas C Friedrich; David H O'Connor; William Rehrauer; Elizabeth J Dodds; Heather Hickman; William Hildebrand; John Sidney; Alessandro Sette; Austin Hughes; Helen Horton; Kathy Vielhuber; Richard Rudersdorf; Ivna P De Souza; Matthew R Reynolds; Todd M Allen; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.

Authors:  Bianca R Mothé; Helen Horton; Donald K Carter; Todd M Allen; Max E Liebl; Pam Skinner; Thorsten U Vogel; Sarah Fuenger; Kathy Vielhuber; William Rehrauer; Nancy Wilson; Genoveffa Franchini; John D Altman; Ashley Haase; Louis J Picker; David B Allison; David I Watkins
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Frequency and function of HIV-specific CD8(+) T cells.

Authors:  S A Migueles; M Connors
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

5.  ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.

Authors:  R Pal; D Venzon; N L Letvin; S Santra; D C Montefiori; N R Miller; E Tryniszewska; M G Lewis; T C VanCott; V Hirsch; R Woodward; A Gibson; M Grace; E Dobratz; P D Markham; Z Hel; J Nacsa; M Klein; J Tartaglia; G Franchini
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.

Authors:  Todd M Allen; Peicheng Jing; Briana Calore; Helen Horton; David H O'Connor; Tomas Hanke; Marian Piekarczyk; Richard Ruddersdorf; Bianca R Mothé; Carol Emerson; Nancy Wilson; Jeffrey D Lifson; Igor M Belyakov; Jay A Berzofsky; Chenxi Wang; David B Allison; David C Montefiori; Ronald C Desrosiers; Steven Wolinsky; Kevin J Kunstman; John D Altman; Alessandro Sette; Andrew J McMichael; David I Watkins
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.

Authors:  Karina Yusim; Can Kesmir; Brian Gaschen; Marylyn M Addo; Marcus Altfeld; Søren Brunak; Alexandre Chigaev; Vincent Detours; Bette T Korber
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission.

Authors:  Anastasia Polycarpou; Christos Ntais; Bette T Korber; Henry A Elrich; Robert Winchester; Paul Krogstad; Steven Wolinsky; Timothy Rostron; Sarah L Rowland-Jones; Arthur J Ammann; John P A Ioannidis
Journal:  AIDS Res Hum Retroviruses       Date:  2002-07-20       Impact factor: 2.205

9.  Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.

Authors:  Xu G Yu; Marylyn M Addo; Eric S Rosenberg; William R Rodriguez; Paul K Lee; Cecily A Fitzpatrick; Mary N Johnston; Daryld Strick; Philip J R Goulder; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys.

Authors:  Thorsten Mühl; Michael Krawczak; Peter Ten Haaft; Gerhard Hunsmann; Ulrike Sauermann
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

View more
  105 in total

1.  Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities.

Authors:  Scott Southwood; Christopher Solomon; Ilka Hoof; Richard Rudersdorf; John Sidney; Bjoern Peters; Angela Wahl; Oriana Hawkins; William Hildebrand; Bianca R Mothé; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-01-28       Impact factor: 2.846

2.  Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8+ T cell responses.

Authors:  Melisa L Budde; Jennifer J Lhost; Benjamin J Burwitz; Ericka A Becker; Charles M Burns; Shelby L O'Connor; Julie A Karl; Roger W Wiseman; Benjamin N Bimber; Guang Lan Zhang; William Hildebrand; Vladimir Brusic; David H O'Connor
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts.

Authors:  Thomas C Friedrich; Adrian B McDermott; Matthew R Reynolds; Shari Piaskowski; Sarah Fuenger; Ivna P De Souza; Richard Rudersdorf; Candice Cullen; Levi J Yant; Lara Vojnov; Jason Stephany; Sarah Martin; David H O'Connor; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  Pyrosequencing reveals restricted patterns of CD8+ T cell escape-associated compensatory mutations in simian immunodeficiency virus.

Authors:  Benjamin J Burwitz; Jonah B Sacha; Jason S Reed; Laura P Newman; Francesca A Norante; Benjamin N Bimber; Nancy A Wilson; David I Watkins; David H O'Connor
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

5.  Variation in CCL3L1 copy number in rhesus macaques (Macaca mulatta).

Authors:  Patrick L Taormina; Jessica A Satkoski Trask; David G Smith; Sreetharan Kanthaswamy
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

6.  Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.

Authors:  Fred W Peyerl; Heidi S Bazick; Michael H Newberg; Dan H Barouch; Joseph Sodroski; Norman L Letvin
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay.

Authors:  John T Loffredo; Eva G Rakasz; Juan Pablo Giraldo; Sean P Spencer; Kelly K Grafton; Sarah R Martin; Gnankang Napoé; Levi J Yant; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.

Authors:  Alessandro Sette; John Sidney; Huynh-Hoa Bui; Marie-France del Guercio; Jeff Alexander; John Loffredo; David I Watkins; Bianca R Mothé
Journal:  Immunogenetics       Date:  2005-03-04       Impact factor: 2.846

9.  Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes.

Authors:  Jason A Wojcechowskyj; Levi J Yant; Roger W Wiseman; Shelby L O'Connor; David H O'Connor
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.

Authors:  Juan P Giraldo-Vela; Richard Rudersdorf; Chungwon Chung; Ying Qi; Lyle T Wallace; Benjamin Bimber; Gretta J Borchardt; Debra L Fisk; Chrystal E Glidden; John T Loffredo; Shari M Piaskowski; Jessica R Furlott; Juan P Morales-Martinez; Nancy A Wilson; William M Rehrauer; Jeffrey D Lifson; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.